eCite Digital Repository

Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?

Citation

Aboy, M and Crespo, C and Liddell, K and Liddicoat, J and Jordan, M, Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?, Nature Biotechnology, 36, (12) pp. 1146-1149. ISSN 1087-0156 (2018) [Refereed Article]

Copyright Statement

Copyright 2018, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

Official URL: https://www.nature.com/articles/nbt.4308

DOI: doi:10.1038/nbt.4308

Abstract

Five years later, what are the wider impacts of the US Supreme Court's Myriad decision on subject-matter eligibility and patent prosecution for nature-based products beyond isolated DNA?

Item Details

Item Type:Refereed Article
Keywords:patent law, DNA, Myriad, USA
Research Division:Law and Legal Studies
Research Group:Law in context
Research Field:Law, science and technology
Objective Division:Law, Politics and Community Services
Objective Group:Justice and the law
Objective Field:Legislation, civil and criminal codes
UTAS Author:Liddicoat, J (Mr John Liddicoat)
ID Code:145065
Year Published:2018
Web of Science® Times Cited:8
Deposited By:Office of the Faculty of Law
Deposited On:2021-06-29
Last Modified:2021-09-09
Downloads:0

Repository Staff Only: item control page